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We analyzed embryo culture medium (CM) and recipient blood plasma using Fourier transform infrared spectroscopy (FTIR)
metabolomics to identify spectralmodels predictive of pregnancy outcome. Embryos collected onDay 6 from superovulated cows in
2 countries were individually cultured in synthetic oviduct fluidmediumwith BSA for 24 h before embryo transfer. Spent CM, blank
controls, and plasma samples (Day 0 andDay 7)were evaluated using FTIR.The spectra obtainedwere analyzed.Thediscrimination
capability of the classifiers was assessed for accuracy, sensitivity (pregnancy), specificity (nonpregnancy), and area under the ROC
curve (AUC). Endpoints considered wereDay 60 pregnancy and birth. HighAUCwas obtained for Day 60 pregnancy in CMwithin
individual laboratories (France AUC = 0.751 ± 0.039, Spain AUC = 0.718 ± 0.024), while cumulative data decreased the AUC
(AUC = 0.604 ± 0.029). Predictions for CM at birth were lower than Day 60 pregnancy. Predictions with plasma at birth improved
cumulative over individual results (Day 0: France AUC = 0.690 ± 0.044; Spain AUC < 0.55; cumulative AUC = 0.747 ± 0.032).
Plasma generally predicted pregnancy and birth better than CM.These first results show that FTIR metabolomics could allow the
identification of embryos and recipients with improved pregnancy viability, which may contribute to increasing the efficiency of
selection schemes based on ET.
1. Introduction
The current increase in the use of embryos selected for
their genetic merit and the need for high fertility recipients
[1, 2] has made the improvement of pregnancy rates upon
embryo transfer (ET) a major objective in cattle farming.
Currently, the selection of cow embryos for ET takes place on
the basis of morphology and development stage. However,
morphological evaluation is a nonobjectivemethod that leads
to discrepant judgments among evaluators [3]. Equivocal
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classification can alter pregnancy rates [4]. Therefore,
improving embryo viability prediction would increase the
efficiency of ET programs.
Assessment of embryonic quality requests noninvasive
or minimally invasive techniques that do not interfere with
embryonic development to term. These conditions restrict
the number of procedures with practical application for ET
programs. In cattle, embryonic cell biopsy is barely used
to evaluate incidence of chromosomal abnormality, while
it is used to detect and quantify expression of some genes
associated with developmental competence [5–7]. However,
gene expression techniques are not extensively used on field,
and biopsy, when associated with freezing in particular, may
compromise embryonic viability [1, 8, 9]. The analysis of the
culture medium (CM) that surrounds the embryo represents
a noninvasive alternative in the search for markers associated
with embryo viability. Single molecules measured in CM in
correlation with embryo viability include glucose, lactate and
pyruvate [10–12], oxygen [13, 14], amino acids [15, 16], and the
proteome profiling [17, 18]. Recently, a noninvasive combined
measurement of developmental kinetics and morphology
with oxygen consumption allowed a reliable prediction of
pregnancy rates from IVP bovine embryos [19].
Together with the particular limitations exposed, the
above methods are technically difficult to perform, time-
consuming, and expensive or require qualified operators [10–
19]. Therefore, more objective and simple approaches are
required to accurately predict embryonic viability in cattle.
Classically less attention has been paid to recipient selec-
tion in the ET field. In practice, selection of recipients is
based on assessment of corpus luteum (CL) function, by
rectal palpation or ultrasonography, and progesterone (P4)
measurement. Such selection procedures help to increase
pregnancy rates but also often exclude too many intrinsically
fertile animals [20–24]. Therefore, developing efficient and
systematic methods for recipient selection is a challenging
and pertinent novel objective for cattle ET technology.
Metabolic analysis of serum or plasma provides a global
profile of the metabolic status. Blood perfuses essentially all
living cells in the body and it carries information on virtually
every cell type. Metabolic changes affect nutrient transport
from blood to oviductal and uterine fluids [25]. Thus, some
compounds of plasma could reflect the ability of a female to
act as a high quality embryo-recipient.
A variety of spectral and analytical approaches may allow
determination of the metabolites associated with embryo
viability and pregnancy outcome [26]. One of the core
approaches of metabolomics is metabolic fingerprinting
(MF), a spectroscopy profile directly dependent on metabo-
lites present in a sample that can anticipate the likelihood for
an event or defined state to occur [27, 28]. In human in vitro
fertilization (IVF), after analyzing culture medium by Raman
and near-infrared spectroscopy (NIR), the MF obtained pre-
dicted viability in oocytes and embryos [29–32]. The results
seemed to be not affected by differences in CM, laboratories,
and days of embryo development nor by fertilization type
(i.e., intracytoplasmic sperm injection versus insemination)
[30, 32]. This indicates that IVP embryos bearing a high
reproductive potential alter their CM differently compared to
embryos that do not lead to pregnancy, although the use of
NIR did not lead to increased pregnancy rates in randomized
prospective trials [33, 34].
By using another spectroscopy technique, Fourier trans-
form infrared spectroscopy (FTIR), we recently developed a
noninvasive system that successfully predicted embryonic sex
[35].
In the present study we analyzed plasma by FTIR
metabolomics to predict pregnancy viability in recipients of
superovulated embryos. In vivo embryo transfer accounts
for approximately 65% of the total embryos transferred
worldwide (source: IETS Newsletter, Dec. 2013). Therefore
improving pregnancy rates by a better selection of embryos
and recipients may contribute to increasing significantly the
efficiency of selection schemes. The “gold standard” in vivo
embryos used were singly cultured in vitro for 24 h and their
CM also analyzed, in order to compare the predictive value
of recipients and embryos (i.e., plasma versus CM, resp.). On
the basis of previous studies with human embryos replicated
in different laboratories and culture conditions [30, 32], we
carried out our experiments in two laboratories with distinct
work procedures.
2. Materials and Methods
All experimental procedures were carried out in accordance
with the European Community Directive 86/609/EC and
were sanctioned by the Animal Research Ethics Committee
of SERIDA (licensed 30/01/09).
Animal experiments with in vivo embryo production
and ET were performed in independent laboratories from
France (UNCEIA, Station Experimentale de Chateauvillain)
and Spain (UTE-Bos).
All reagents were purchased from SIGMA (Madrid,
Spain) unless otherwise stated.
2.1. Production and In Vitro Culture of In Vivo Embryos. In
vivo embryo production methods differed between Spanish
and French laboratories involved.
In UTE-Bos (Spain), cyclic, Holstein donor cows were
synchronized in estrus. Briefly, a progestagen device (PRID;
Ceva, France) was inserted in the vagina. OnDay (−5), 8 FSH
(Folltropin, Bioniche, Canada) decreasing doses were given
every 12 h apart. OnDays (−3) pm and (−2) am, cows received
prostaglandin F
2
𝛼 analogue (2mL Dalmazin; Fatro Ibe´rica,
Spain). On Day (−2) the progestagen device was removed
and donors were injected with 2mL GnRH (Dalmarelin,
Fatro Iberica, Spain). On Day 0, animals showing estrus
were inseminated twice at 12 h intervals. Inseminations were
performed with 𝑛 = 4 bulls.
In UNCEIA (France) cyclic, lactating Holstein donor
cows housed in station were synchronized in estrus by
using progestagen implants and prostaglandin F
2
𝛼 (PG),
as prescribed by the manufacturer (Crestar method, Inter-
vet, France). The animals came into heat 48 h after the
implant removal (=Day 0). Starting on Day 10, animals
were superovulated with a total dose of 500𝜇g FSH (Stimu-
fol, Reprobiol, Belgium) given as twice daily injections in
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a decreasing dose 4-day schedule. At the 5th FSH injection,
a PG injection was given. Animals showing estrus 48 h after
prostaglandin F
2
𝛼 injection were inseminated twice at 12 h
intervals. Inseminations were performed with 𝑛 = 6 bulls.
In both the UTE-Bos and UNCEIA laboratories embryo
recovery was performed by flushing the uterine horns on
Day 6 in the cycle. Recovered embryos were in vitro cultured
in synthetic oviduct fluid containing amino-acids, citrate,
and myo-inositol supplemented with 6 g/L BSA (SOFaaci) in
single 12𝜇L drops for 24 h. Atmosphere conditions were 5%
CO
2
in air (UTE-Bos) and 5% CO
2
, 5% O
2
in air in UNCEIA.
The SOFaaci compounds used were the same in the two
laboratories involved, and culture medium in UTE-Bos was
prepared in SERIDA. At the end of the culture period (Day
7), embryos were loaded in straws for ET.
2.2. Estrus Synchronization of Recipients. InUTE-Bos, heifers
were synchronized in estrus with intravaginal progestagen
device (PRIDALPHA, Ceva, Barcelona, Spain) for 8 days and
a PG analogue (Dalmazin) injected 24 h before progestagen
removal. A GnRH analogue (Dalmarelin) was injected at the
time of progestagen insertion and on Day 0.
In UNCEIA, heifers were synchronized in estrus with
progestagen implant (Crestar, Intervet, France) for 10 days
combined with a PG analogue (Estrumate, Intervet, France)
injected 24 h before progestagen removal.
2.3. CultureMedia and Embryo Recovery for Viability Analysis
and Embryo Transfer. Spent culture media (10 𝜇L) and blank
controls (i.e., droplets incubated without embryos in them;
up to 4 blank controls per batch of embryos cultured
simultaneously) were collected on Day 7 and stored frozen
at −80∘C up to FTIR analysis. On Day 7, single embryos were
nonsurgically transferred to recipients in the cranial third of
the uterine horn ipsilateral to CL under epidural anesthesia.
2.4. Recipient Blood Sampling for Plasma Viability Analysis.
Blood plasma samples from recipients were taken in EDTA-
vacuum tubes from coccygeal vein puncture. Samples were
taken at the time of standing estrus (Day 0) and on Day 7
(2–4 h before the ET time). Blood tubes were immediately
refrigerated at +4∘C, and centrifuged at 2,000×g, not later
than 30min after recovery. Supernatant plasmawas aliquoted
and stored at −80∘C up to FTIR analysis.
2.5. Pregnancy Diagnosis. In both places and all recipients,
pregnancy was diagnosed by transrectal ultrasound scanning
on Days 60 ± 2, and birth date registered.
2.6. FTIR Metabolomic Analysis. Spent CM and blank sam-
ples were analyzed using a Golden-Gate ATR device (dia-
mond crystal)mounted on aVarian 620-IR FTIR spectropho-
tometer running Varian Resolutions Pro software version
5.0.0.700. 5 𝜇L of the sample was dropped on the ATR
diamond and evaporated under a dry N
2
flow until the FTIR
spectrumwas stable and different from that of thewater. FTIR
spectra (16 measurements per sample) were collected in the
spectral range between 600 and 4000 cm−1, at 5 kHz speed
and 4 cm−1 resolution. The relative standard deviation was
lower than 3% at every wavelength in the range between 600
and 3500 cm−1 (excluding the CO
2
zone).
2.7. Spectral Model Development. The FTIR spectra obtained
from CM and blood plasma were uploaded to Matlab pro-
gramming environment (R2011b; The MathWorks, Natick,
MA) for data analysis and predictive model development.
Two separate datasets were generated considering Day 60
pregnancy and birth endpoints. In each dataset, samples
were labeled as 1 and −1 associated with positive and nega-
tive outcomes, respectively. Binary (two-class) classification
experiments were performed for model development.
The overall study population included spectra obtained
from CM of embryos transferred (𝑛 = 26 in France and
𝑛 = 23 in Spain). Individual spectral profiles were normalized
to the control medium to account for possible impact of
variations in the culture conditions. Data corresponding
to CO
2
frequency band (2285–2400 cm−1) were removed
from the analysis. Each sample was then represented as
a row vector of spectra data and the corresponding class
label. Spectra from Day 0 and Day 7 plasma obtained from
recipients transferred were also analyzed.
In a recent study, we performed a benchmarking exper-
iment to assess discrimination capability of a variety of
classification algorithms on prediction of embryonic sex
using CM spectra (submitted). Among the classifiers tested,
k-nearest neighbor (k-NN) provided the highest prediction
accuracy. Therefore, we applied k-NN method for viability
prediction in this study.
In the distance based local k-NN model the class label of
a test sample is decided to be the same as the most frequent
class among its 𝑘 neighborhood. k-NNmethod provides local
solutions assuming that samples which are close together in
the feature space will belong to the same class. The distances
of each test sample to all training samples are calculated and
sorted ascendingly. The majority of the class among shortest
𝑘 distances is chosen as the class of the test sample. As the
most general distance metric of k-NN algorithm, Euclidean
distance was used in the experiments.The Euclidean distance
𝑑(𝑝, 𝑞) between the two points 𝑝 and 𝑞 in 𝑁 dimensional
space is
𝑑 (𝑝, 𝑞) = 𝑠𝑞𝑟𝑡(
𝑁
∑
𝑖=1
(𝑝
𝑖
− 𝑞
𝑖
)
2
) . (1)
Specifically, a weighted k-NN approach was applied
where the contributions of neighbors to the class choice were
weighted by the inverse of distances to the test sample.
The study dataset is a typical example of high dimension
low sample size (HDLSS) problem with 49 samples of
CM, 96 samples from plasma, and 1704 features, obtained
from spectroscopy analysis.We utilized principal component
analysis (PCA) to spectra data for dimensionality reduction.
2.8. Training and Testing Strategy. We applied 10-fold cross
validation training-testing strategy in the classification exper-
iments.The entire dataset was randomly divided into 10 bins.
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Table 1: Day 60 pregnancy and birth predictions on PCA transformed spectra data derived from metabolomic analysis of spent culture
medium (CM) of Day 6 in vivo embryos cultured in vitro for 24 h and transferred fresh to recipients on Day 7 in two laboratories (UNCEIA,
France, and UTE-Bos, Spain).
Laboratory Sample analyzed Pregnancy endpoint 𝑁 Positive Negative 𝑘 PCA Accuracy Sensitivity Specificity AUC
France Embryo CM Day 60 26 16 10 3 + 74.6 ± 5.5 75.0 ± 4.2 74.0 ± 8.4 0.751 ± 0.039
Birth 26 14 12 3 + 68.5 ± 7.6 69.3 ± 7.6 67.5 ± 9.2 0.655 ± 0.075
Spain Embryo CM Day 60 23 13 10 3 + 74.8 ± 3.9 67.7 ± 7.1 84.0 ± 6.9 0.718 ± 0.024
Birth 23 12 11 3 + 66.9 ± 4.2 58.3 ± 6.8 76.3 ± 4.7 0.625 ± 0.032
France + Spain Embryo CM Day 60 49 29 20 3 − 64.4 ± 1.4 57.5 ± 2.7 74.4 ± 5.8 0.604 ± 0.029
Birth 49 26 23 3 − <0.6
𝑁: culture medium or plasma samples analyzed. Positive: samples that correspond to pregnancy/birth. Negative: samples that do not correspond to
pregnancy/birth.
𝑘: adjustable model parameter of 𝑘-nearest neighbor classification algorithm.
PCA: principal component analysis (+: applied; −: did not improve the results when applied).
The predictive model was developed on the 9 bins (training
samples) and the performance of prediction was assessed
on the remaining bin (test samples). In order to overcome
sampling bias, the training-testing procedure was repeated 10
times replacing the test samples with a bin from the training
samples. The average results obtained from the repeated tests
are presented.
The discrimination capability of the classifiers was
assessed in terms of accuracy, sensitivity and specificity (i.e.,
the proportion of correctly detected positive and negative
pregnancy outcomes, resp.), and receiver operating charac-
teristics curve (ROC) analysis [36]. The ROC curve plots
the sensitivity versus 1-specificity by adjusting the decision
threshold of classification. ROC analysis enables comparison
of classifiers using area under the ROC curve (AUC) as the
single performance measure where the classifier with the
largest AUC dominates the others.
2.9. Experimental Design. In Experiment 1, we obtained the
metabolomic profile of individually cultured embryos, upon
FTIR analysis of frozen/thawed CM samples of 24 h in vitro-
cultured, in vivo-derived fresh embryos. Values were normal-
ized versus those of blank samples cultured without embryos.
Predictive models compared pregnant versus nonpregnant
animals on Day 60 and at birth within all categories of
embryos analyzed.
In Experiment 2, we predicted pregnancy success from
recipient plasma metabolomic analysis. For normalization
purposes, in the absence of blank controls, we included two
days of plasma sampling. Our aim was that subtraction of
Day 0 and Day 7 plasma values could be an appropriate tool
to normalize recipient data between laboratories. Therefore,
plasma spectral values were analyzed on Day 0 and Day 7,
each being an independent prediction day, and normalized
(i.e., Day 7 and Day 0).
2.10. Statistics. All spectral model development, data pre-
processing steps, and postprediction statistical analysis were
performed using Matlab (R2011b; The MathWorks, Natick,
MA). Classifier benchmarking tasks were conducted using
Weka (Waikato Environment for Knowledge Analysis), an
open-source data mining system [37]. The significance of
the differences between the predictive spectral models tested
was assessed by comparing the associated AUC values using
ANOVAor 𝑡-test when appropriate. A risk alpha of <0.05 was
considered significant for the comparisons.
3. Results
3.1. Embryo Transfer and Pregnancies. Day 6 in vivo recov-
ered early morulae (𝑛 = 51) were individually cultured
for 24 h. Only embryos that developed in vitro up to late
morula to expanded blastocyst stages (𝑛 = 49) were
transferred fresh on Day 7 to synchronized recipients in two
experimental herds (UNCEIA, 𝑛 = 26, andUTE-Bos, 𝑛 = 23)
(Table 3). Samples of CM from all embryos transferred and
the corresponding plasma from recipients were recovered
and processed. Day 60 pregnancy and birth rates were >50%
(Table 3).
3.2. Pregnancy Predictions with CM and Recipient Plasma.
Day 60 pregnancies in each individual laboratory involved
and within cumulative data were higher than predictions at
birth (Table 1). However, cumulative predictions at Day 60
from CM were lower than individual laboratory predictions
(France: accuracy = 74.6 ± 5.5, AUC = 0.751 ± 0.039; Spain:
accuracy: 74.8 ± 3.9, AUC = 0.718 ± 0.024; cumulative:
accuracy = 64.4 ± 1.4, AUC = 0.604 ± 0.029).
In contrast, cumulative analysis improved predictions
with plasma (Table 2) on Day 60 and at birth when compared
to individual results (birth predictions with Day 0 plasma
from France: accuracy = 66.4 ± 7.1, AUC = 0.690 ± 0.044;
Spain: accuracy and AUC < 0.55; cumulative: accuracy =
72.1 ± 2.0, AUC = 0.747 ± 0.032). Spectra profiles of
birth predictions from Day 0 plasma are visualized in a 3D
principal component space (Figure 1).
Plasma Day 0 gave AUC and accuracy cumulative values
higher than those from Day 0 to Day 7 normalized.
4. Discussion
We show here that CM metabolome reflects viability of in
vivo embryos and that the metabolic fingerprint of recipient
plasma provides robust information on the likelihood of
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Table 2: Day 60 pregnancy and birth predictions on PCA transformed spectra data derived from metabolomic analysis of plasma recovered
onDay 0 andDay 7 from recipients prior to transfer onDay 7 of embryos that had been cultured in vitro for 24 h in two laboratories (UNCEIA,
France, and UTE-Bos, Spain).
Laboratory Plasma analyzed Pregnancy endpoint 𝑁 Positive Negative 𝑘 PCA Accuracy Sensitivity Specificity AUC
France Day 0 Day 60 25 15 10 3 − 59.6 ± 4.4 58.7 ± 6.9 61.0 ± 5.7 0.657 ± 0.033
Birth 25 13 12 3 − 66.4 ± 7.1 73.1 ± 15.5 59.1 ± 9.2 0.690 ± 0.044
France Day 7–Day 0 Day 60 25 15 10 3 − <0.6
Birth 25 13 12 3 − 72.0 ± 3.8 69.7 ± 10.2 75.0 ± 8.8 0.789 ± 0.032
Spain Day 0 Day 60 23 13 10 1 − 69.1 ± 5.2 72.8 ± 9.1 62.0 ± 6.3 0.671 ± 0.067
Birth 23 12 11 1 − <0.55
Spain Day 7–Day 0 Day 60 23 13 10 3 + 68.3 ± 9.6 73.8 ± 15.5 61.0 ± 3.2 0.639 ± 0.047
Birth 23 12 11 3 + 67.8 ± 3.0 69.2 ± 5.6 66.3 ± 4.4 0.662 ± 0.021
France + Spain Day 0 Day 60 48 28 20 1 + 74.2 ± 1.1 78.2 ± 3.1 70.7 ± 1.1 0.766 ± 0.014
Birth 48 25 23 1 + 72.1 ± 2.0 79.2 ± 7.3 64.4 ± 7.0 0.747 ± 0.032
France + Spain Day 7–Day 0 Day 60 48 28 20 3 + <0.6
Birth 48 25 23 3 + 69.8 ± 6.0 58.4 ± 3.4 82.2 ± 9.5 0.657 ± 0.033
𝑁: culture medium or plasma samples analyzed. Positive: samples that correspond to pregnancy/birth. Negative: samples that do not correspond to
pregnancy/birth.
𝑘: adjustable model parameter of 𝑘-nearest neighbor classification algorithm.
PCA: principal component analysis (+: applied; −: did not improve the results when applied).
Day 7 plasma alone (not represented) yields <0.6 AUC.
Table 3: In vitro development and pregnancy rates of Day 6 in vivo embryos that recovered from superovulated, artificially inseminated cows
in UNCEIA (France) and UTE-Bos (Spain) followed by a 24 h individual culture step in SOF + 6 g BSA/L prior to embryo transfer.
Development rates
Laboratory 𝑁1 𝑁2 𝑁3 Day 60 pregnancy Calving
France 27 26 26 17 (65%) 16 (61%)
Spain 24 23 23 13 (56%) 12 (52%)
Total 51 49 49 30 (59%) 28 (55%)
𝑁1: early embryos, morulae, flushed and cultured in vitro.
𝑁2: embryos developed to a transferable stage after a 24 h in vitro culture.
𝑁3: embryos transferred to recipients (used once for ET).
France: all embryos were transferred in a single herd (𝑛 = 5 bulls).
Spain: embryos transferred in 2 herds (𝑛 = 4 bulls).
pregnancy and birth. The embryo produced in vitro shows
capacity to modify its environment early in development.
Thus, in the cow uterus, IVP early embryos trigger detectable
maternal responses on Day 8 in the uterine fluid [38], which
also changes according to the embryonic sex [39]. Using IVP
embryos, sex differences were also captured in the CM with
the same FTIR techniques used in this work [35]. In this
work, the MF of CM was affected by dissimilar laboratorial
procedures, different embryo-donor management, or both.
In contrast, results from recipient plasma overcame man-
agement differences between the two recipient herds used,
leading to accuracy and AUC values, both on Day 60 and
at birth (all of them >0.72), higher than those from the two
laboratories analyzed separately.
The present findings suggest that the predictive value of
CM is limited with in vivo embryos, and future work should
consider gaining insight into normalization procedures. Nor-
malization should include classification by embryonic stages
with higher sample numbers, andprobably culture conditions
and time periods other than 24 h.
We did not estimate the effects of 24 h in vitro culture
on in vivo embryos after transfer. However, Grade 3 morulae
that recovered from superovulated animals yield pregnancy
rates similar to noncultured Grade 1 morulae after 24 h in
vitro culture [40]. This is consistent with the information
from these authors showing that 24 h in vitro culture can be a
successful choice for low quality and/or delayed embryos that
recovered from flushing.
CM from in vivo embryos was less predictive for birth
than for Day 60 pregnancy rates. This is surprising, as
recipients carrying in vivo-derived embryos usually show
less than 5% embryonic losses from the second month of
pregnancy to term [41], a lower rate than IVP embryos [41–
43]. Further research is needed so as to investigate whether
CM can be representative of these differences between both
types of embryos.
The viability profiles of CMwith in vivo embryoswere not
more efficient than conventional selection of embryos. Inter-
estingly, the plasma recipient was generally more predictive
of pregnancy success than the CM profile.Within cumulative
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Figure 1: Principal component analysis (PCA) of spectra obtained
from Day 0 plasma. The percentages of variability represented by
the first three principal components are displayed across PC nos. 1,
2, and 3 on𝑋, 𝑌, and 𝑍 axes, respectively.
results, plasma Day 0 gave AUC and accuracy values higher
than those from Day 0 to Day 7 normalized, indicating
that (combinations of) factors exist in single Day 0 samples
able to act as internal controls. Information from recipient
(plasma) was generally more predictive of pregnancy success
than the embryo CM. Recipient plasma can be affected
by different feeding, management, and environmental con-
ditions. However, Day 0 plasma enabled identification of
common predictive profiles between recipient herds with
an AUC higher than those from each laboratory analyzed
apart. These data suggest that two-day sampling could not be
necessary, once single plasma samples on Day 0 may provide
endogenous normalization.
The ability of a recipient to reach birth has been suggested
to be a source of variation higher than the ability of the
embryo to survive to term [44–46]. In addition, variation
in recipient quality has been shown not to be an important
contribution to fetal loss from Day 60 to term [44]. Effective
identification of the higher recipient variability by FTIR
could explain the superior predictive ability of the animals
versus the embryo. It has been predicted that there are
intrinsically superior recipients within individual herds [46].
Superior recipient heifers may show changes in endometrial
expression of genes and proteins [7, 47–49] affecting major
metabolic pathways and immune response. Some ET practi-
tioners are becoming aware of this and retain recipients that
successfully delivered calves after ET for future transfers.
To our knowledge, the association of embryos with
specific recipients has been not yet studied, and it could
help optimize the use of recipient herds. Promising research
lines can investigate recipients that are usually discarded
for ET using conventional selection criteria. In addition,
as recipients and embryos can enter into an early dialogue
into which immunological concerns are prominent [38, 39],
compatibility between specific embryos (CM) and recipients
(plasma) may exist and should be further investigated.
5. Concluding Remarks
Selection of in vivo embryos by FTIR analysis of CM to
increase pregnancy rates may be performed. Although this
approach did not improve the results obtained with conven-
tional selection of in vivo embryos, it is likely that establishing
more homogeneous procedures may allow normalization
between laboratories leading to improved prediction rates. In
contrast, cumulative analysis of recipient plasma from both
laboratories identified pregnancy predictive profiles with an
AUC higher than those from each laboratory analyzed apart,
suggesting that FTIR can be an interesting, simple tool to
select recipients on field in conventional MOET programs.
FTIR analysis of CM provides a noninvasive, rapid, and
inexpensive method compatible with the highest sanitary
standards and international exchanges of embryos. Using
embryos and recipients with improved viability indexes will
significantly increase pregnancy rates and economic benefit
in the cattle breeding industry.
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